2009
DOI: 10.2174/156802609788340805
|View full text |Cite
|
Sign up to set email alerts
|

Soluble Epoxide Hydrolase, a Target with Multiple Opportunities for Cardiovascular Drug Discovery

Abstract: Soluble epoxide hydrolase (sEH) is a cross-functional target, with the potential for therapeutic utility in the areas of hypertension, inflammation, and organ-protection. Promising target validation has emerged around soluble epoxide hydrolase in recent years which suggests that small molecule inhibitors may have utility in cardio protection, glucose regulation, hypertension, inflammation, and organ protection. Based on the diversity of chemical classes of sEH inhibitors reported in the literature, there exist… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
56
0

Year Published

2010
2010
2016
2016

Publication Types

Select...
8
1
1

Relationship

0
10

Authors

Journals

citations
Cited by 43 publications
(57 citation statements)
references
References 0 publications
1
56
0
Order By: Relevance
“…Cytochrome P450 enzymes could participate in the syntheses of prostaglandins known to be secreted in tick saliva [28-32]. Soluble epoxide hydrolases, if secreted, may affect host prostanoids [33, 34]. Some CDS of sphingomyelinases and deoxyribonucleases also show presence of signal peptides; such secreted enzymes could affect host immunity signaling [35] and affect host neutrophil extracellular traps (NETs) [36], respectively.…”
Section: Resultsmentioning
confidence: 99%
“…Cytochrome P450 enzymes could participate in the syntheses of prostaglandins known to be secreted in tick saliva [28-32]. Soluble epoxide hydrolases, if secreted, may affect host prostanoids [33, 34]. Some CDS of sphingomyelinases and deoxyribonucleases also show presence of signal peptides; such secreted enzymes could affect host immunity signaling [35] and affect host neutrophil extracellular traps (NETs) [36], respectively.…”
Section: Resultsmentioning
confidence: 99%
“…51,53 This development of sEH inhibitors has been extensively chronicled in a number of excellent review articles. 51,54,55 …”
Section: Therapeutic Approaches – Hypertension and Kidney Diseasesmentioning
confidence: 99%
“…Because EET turnover by EH is evolving as a promising target for therapeutic intervention ( 11 ) and, in particular, with the expected role of D173 as the catalytic nucleophile because self-activation by autocatalytic hydrolysis from the mutant asparagine to the wild-type aspartic acid side chain has been reported for the equivalent mutants of other EHs ( 34,35 ).…”
Section: Eh3 Is Inhibited By Urea Derivatives Regarded As Specifi C Fmentioning
confidence: 99%